Plain-English translation of NCT07325240 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether Rocklatan, a combination eye drop that contains two active ingredients, works better than latanoprost alone at lowering the pressure inside your eyes. You would use one medication in one eye and the other medication in your other eye for two weeks, and researchers would measure how well each one controls your eye pressure throughout the day and night.
Glaucoma and high eye pressure can damage your vision over time, and doctors want to find the most effective ways to control eye pressure. This study will help determine whether the new two-ingredient medication offers better pressure control than the current single-ingredient treatment.
You likely qualify if…
You likely don't qualify if…
You would come to the clinic for several visits over about 10 weeks. First, you may need to stop taking any current glaucoma medications for a washout period. Then, you would put one medication in one eye and the other medication in your other eye every evening for 14 days. Researchers would measure your eye pressure multiple times during the study, including special measurements taken over a full 24-hour period to see how each medication controls pressure day and night.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States